| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |